Terns Pharmaceuticals Inc (NASDAQ:TERN) concluded the trading at $3.05 on current market day with a rise of 5.90% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.88 and 5Y monthly beta
Terns Pharmaceuticals Inc (NASDAQ:TERN) traded at $2.81 at last check on current trade day and made an upward move of 17.04% on its previous day’s price. Looking at the stock we see that its previous close was $2.40 and the beta (5Y monthly) reads -0.141
Terns Pharmaceuticals Inc (NASDAQ:TERN) price on Thursday, April 10, fall -6.96% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.14. A look at the stock’s price movement, the close in the last trading session was $2.30, moving
Terns Pharmaceuticals Inc (NASDAQ:TERN) price closed lower on Friday, April 04, and dropping -9.87% below its previous close. A look at the daily price movement shows that the last close reads $2.33, with intraday deals fluctuated between $2.08 and $2.29. The company’s 5Y monthly beta
Terns Pharmaceuticals Inc (NASDAQ:TERN) traded at $2.76 at close of the session on Monday, March 31 and made a downward move of -5.48% on its previous day’s price. Looking at the stock we see that its previous close was $2.92 and the beta (5Y monthly)
The trading price of Terns Pharmaceuticals Inc (NASDAQ:TERN) closed higher on Friday, March 21, and closing at $3.35, 6.69% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $3.16 and $3.72. In examining the
Terns Pharmaceuticals Inc (NASDAQ:TERN) price closed higher on Monday, March 17, and jumping 2.20% above its previous close. A look at the daily price movement shows that the last close reads $3.18, with intraday deals fluctuated between $3.08 and $3.2936. The company’s 5Y monthly beta
Terns Pharmaceuticals Inc (NASDAQ:TERN) traded at $3.48 at close of the session on Tuesday, March 11 and made an upward move of 3.57% on its previous day’s price. Terns Pharmaceuticals Inc has a market cap of $295.59 million and is expected to release its quarterly
Terns Pharmaceuticals Inc (NASDAQ:TERN) shares, rose in value on Friday, March 07, with the stock price down by -3.86% to the previous day’s close as strong demand from buyers drove the stock to $3.49. Actively observing the price movement in the last trading, the stock
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
